In 2021, Yamamoto et al. found that rosmarinic acid suppresses Aβ-induced inflammation by downregulating JNK-mediated signaling in the hippocampus after 8 treatment months in a triple-transgenic mouse model of AD [65]. This evidence concerns the gene MAPK8 and Alzheimer disease.